On the origins of Mendelian disease genes in man: the impact of gene duplication by Dickerson, Jonathan E. & Robertson, David L.
On the Origins of Mendelian Disease Genes in Man:
The Impact of Gene Duplication
Jonathan E. Dickerson and David L. Robertson∗
Computational and Evolutionary Biology, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom
*Corresponding author: E-mail: david.robertson@manchester.ac.uk.
Associate editor: James O. McInerney
Abstract
Over 3,000 human diseases are known to be linked to heritable genetic variation,mapping to over 1,700 unique genes. Dating
of the evolutionary age of these disease-associated genes has suggested that they have a tendency to be ancient, specifically
coming into existence with early metazoa. The approach taken by past studies, however, assumes that the age of a disease
is the same as the age of its common ancestor, ignoring the fundamental contribution of duplication events in the evolu-
tion of new genes and function. Here, we date both the common ancestor and the duplication history of known human
disease-associated genes. We find that the majority of disease genes (80%) are genes that have been duplicated in their evo-
lutionary history. Periods for which there are more disease-associated genes, for example, at the origins of bony vertebrates,
are explained by the emergence of more genes at that time, and the majority of these are duplicates inferred to have arisen
by whole-genome duplication. These relationships are similar for different disease types and the disease-associated gene’s
cellular function. This indicates that the emergence of duplication-associated diseases has been ongoing and approximately
constant (relative to the retention of duplicate genes) throughout the evolution of life. This continued until approximately
390 Ma from which time relatively fewer novel genes came into existence on the human lineage, let alone disease genes. For
single-copy genes associatedwith disease, we find that the numbers of disease genes decreases with recency. For the majority
of duplicates, the disease-associatedmutation is associated with just one of the duplicate copies. A universal explanation for
heritable disease is, thus, that it ismerely a by-product of the evolutionary process; the evolution of new genes (de novo or by
duplication) results in the potential for new diseases to emerge.
Key words: human disease genes, evolution and origins of disease, gene duplication, whole-genome duplication, gene
retention.
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Introduction
Sequencing of the human genome is permitting a detailed
characterization of the genetics underpinning human
disease (Altshuler et al. 2008) and thousands of polymor-
phisms associatedwith disease have been linked to heritable
mutations (Hamoshet al. 2005). Although it is of paramount
importance to understand the aetiology of specific diseases
in this way, it is also interesting to consider the origins of
genetic diseasemore generally. Results of evolutionary stud-
ies have reported that the age of disease-associated genes
is heavily biased, in that they tend to be ancient, with a
tendency to arise with early metazoa (Lo´pez-Bigas and
Ouzounis 2004; Domazet-Loso and Tautz 2008; Cai et al.
2009). As it is inherently difficult to identify the first emer-
gence of a specific disease, it is assumed that the evolution-
ary age of a disease is the same as the origin of the gene
the disease is associated with, that is, the inferred presence
of the gene in the most recent common ancestor of extant
species (Lo´pez-Bigas andOuzounis 2004; Domazet-Loso and
Tautz 2008). Focusing on common ancestors without con-
sidering a gene’s duplication history will, however, only
permit a superficial understanding of disease origins.
This limitation is because functional innovation is rarely
achieved via the de novo genesis of genes. Rather, new
genes are most frequently generated by duplication either
in whole or from part of existing genes (Ohno 1970; Lynch
and Conery 2000; Long et al. 2003; Conant andWolfe 2008).
Duplicate genetic material is inherently redundant and so
less prone to purifying selection. As a consequence, one of
the duplicate copies will tend to accumulate mutations and
become a nonfunctional pseudogene (termed pseudoge-
nization). On occasion, mutations (either existing or new)
can be selectively advantageous contributing to the evo-
lution of novel function (neofunctionalization) or in the
partitioningof existing functions (subfunctionalization) and
become fixed. In this way, a duplicate copy of a gene can
become associated with a different phenotype to its par-
alogous partner. This has consequences for linking disease
phenotypes to genes.
Specifically, a disease-associated gene should be associ-
ated with a particular duplicate rather than the common
ancestor of its gene family. As most Mendelian diseases
are only characterized on evolutionary recent taxa, it is
reasonable—despite being an underestimate—to use
the most recent duplication node (MRD) of a human
disease-associated gene as a proxy for disease origin. For
example, the disease epilepsy cannot exist prior to thedevel-
opment of themammalian brain andneurotransmitters, for
Mol. Biol. Evol. 29(1):61–69. 2012 doi:10.1093/molbev/msr111 Advance Access publication June 24, 2011 61
 The Author 2011. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Open Access
 at Periodicals D
ept on A
ugust 16, 2016
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
Dickerson and Robertson · doi:10.1093/molbev/msr111 MBE
example, GABA1. Indeed, without considering duplication,
GABA1 receptor’s “age” would be misleadingly reported as
its common ancestor, in this case an evolutionary ancient
premetazoan origin. Such failure to include duplication his-
tory when dating disease-associatedgenes has the potential
to misclassify the origin of a disease as erroneously ancient.
To test this hypothesis, we date both the most recent com-
mon ancestor and the duplication history of known human
disease genes.
We find, as previous evolutionary studies have, that the
majority of disease genes have common ancestors with an
origin predating animals that evolved bilaterian symmetry
(Bilateria) greater than one billion years ago (Lo´pez-Bigas
and Ouzounis 2004; Domazet-Loso and Tautz 2008). How-
ever, 80% of these disease genes have a duplication history
and the most recent of these duplications do not map back
to Bilateria rather themajority came into existencewith the
radiation of the bony vertebrates (Chordata–Euteleostomi),
some 500–600 Ma. Interestingly, the proportion of disease-
associated genes with a duplicate history approximately
“tracks” the overall distribution of duplicated genes until
390 Ma and is independent of host protein function or dis-
ease class. Singletons (genes present only as single copies)
that are disease genes decline in numbers with recency.
We also find a strikingly asymmetric distribution of disease
genes in gene families, with a tendency for only one mem-
ber of a gene family to be diseased associated. We discuss
the implications of these findings on our understanding of
Mendelian disease origins.
Methods
Assigning an Age to Human Genes
Althoughwe cannot definitively identify the first emergence
of a diseasemutation, we can identify the origin, or “age,” of
the linked disease gene by inferring the most recent com-
mon ancestor (as indicated by taxonomic level) of all ex-
tant species from the tree of life that have homologs to this
gene (supplementary fig. S1, Supplementary Material on-
line). To identify the origin of individual human genes (dis-
ease associated or otherwise), we downloaded evolutionary
trees generated from EnsemblCompara multispecies com-
parisons in Ensembl release 56 (ftp://ftp.ensembl.org/pub;
Flicek et al. 2009), which included 51 species. In Ensem-
blCompara, molecular phylogenies for each gene have been
inferred using orthology and paralogy gene prediction anal-
ysis. The longest translation of every identified protein-
coding gene has been queried against each species protein
in Ensembl using BlastP. Clusters of homologous genes,
which will include gene families from each genome, have
been extracted and aligned using MUSCLE (Edgar 2004),
and the resulting multiple alignment used to generate a
tree with TreeBeST from TreeFam (Li et al. 2006). The
TreeBesT framework incorporates a number of sophisti-
cated phylogenetic methods including DNA, codon, and
protein maximum likelihood methods. A combined tree
is then generated to integrate the different phylogenetic
results. DNA or codon-based methods are used for parts of
the phylogeny that exhibit shorter evolutionary distances,
for example, intraclass comparisons, whereas protein infor-
mation is used for longer evolutionary distances, for ex-
ample, comparisons between classes (Vilella et al. 2009).
We then query the EnsemblCompara phylogenies to iden-
tify the age of each human gene (its taxonomic level) and
whether it has duplicated or is a singleton, a gene present
once in the human genome with no identifiable duplication
history. Note that the reliable identificationof singletonsas-
sumes both detectable homology and the retention of any
duplicates on multiple lineages.
For each duplicated human gene, we identified both
DCA, the taxonomic level associated with the duplicate’s
common ancestor, and MRD, the taxonomic level associ-
ated with the “most recent duplication node.” For example,
we assign the chloride channel Ka gene CLCNKA as having
an MRD of Catarrhini and a DCA of Bilateria based on its
duplication history (supplementary fig. S2A, Supplemen-
tary Material online). For MRDs, we also identified those
whose origin has been attributed to whole-genome dupli-
cation (Makino and McLysaght 2010). For each singleton,
we identified SCA the taxonomic level associated with the
“singleton’s common ancestor.” For example, we assign the
histidine–proline-rich glycoprotein gene HRG an SCA of
Coelomata (supplementary fig. S2B, Supplementary Mate-
rial online). Putative, uncharacterized and undetermined
taxonomic levels, and ambiguous mappings were excluded
from our classifications. Taxonomic levels without repre-
sentation amongst both duplicates and singletons were
not considered for evolutionaryhistory analyses (specifically
Coelomata and Euarchontoglires), but were considered for
disease type, gene function, and selection analyses if suffi-
cient data were available.
The approximate evolutionary ages of taxonomic lev-
els were obtained using a consensus of multiple sources
(Benton and Ayala 2003; Hedges et al. 2006; Benton and
Donoghue 2007; Donoghue and Benton 2007). Note that
this use of divergence dates of common ancestors based
on the molecular phylogeny for dating disease origin will
always be a more recent estimate as they will coincide
with speciation events, whereas the disease-associatedmu-
tationcould have existedprior to speciation.Ensembl genes
were mapped to NCBI gene identifiers wherever possible to
facilitate data integration.
Mapping Diseases to Human Genes
Disease-associated genes were obtained from Online
Mendelian Inheritance in Man (OMIM; Hamosh et al.
2005) and filtered to include only those genes where strong
evidence that at least one mutation in the particular
gene is causative of the disease. This resulted in 3,328
unique diseases across 1,755 unique genes. These data
were cross-referenced with our ancestor data to yield 1,324
disease-associated genes with MRD/DCA annotations and
331 with SCA annotations. A common ancestor was not
identifiable for 100 disease-associated genes.
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Functional Analysis of Diseases, Genes, and Age
Medical Subject Headings (MeSH; http://www.nlm.nih.gov/
mesh), which, in addition to other life science cate-
gories, hierarchically describe disease, for example, diseases
to digestive system, neoplasms, etc., were downloaded
and filtered for the “Diseases [C]” annotation. Nine-
teen top level categories were selected from the MeSH
trees (http://www.nlm.nih.gov/mesh/filelist.html) that are
representative of high-level classifications. These were
merged with 22 disease categories and annotations from
(Goh et al. 2007) to give 16 unique disease categories and
provide a consistent annotation of disease. Each disease-
associated gene was then labeled with the related category
to yield higher level annotation (supplementary table S1,
SupplementaryMaterial online).
Using the Gene Ontology (GO)—a set of three struc-
tured controlled ontologies that describes gene products in
terms of their associated biological processes, cellular com-
partments, or molecular functions (Harris et al. 2004)—a
gene can be annotated with multiple GO terms from each
of the ontologies, for example, “immune response,” “plasma
membrane,” and “coreceptor activity,” respectively. GO
terms were collected for each human gene from the NCBI
“gene2go” file (ftp://ftp.ncbi.nlm.nih.gov/gene/DATA).
Term ancestors were then identified for each term from
“gene ontology edit.obo” (http://www.geneontology.org)
to ensure complete coverage. A GO slim (a cut down ver-
sion of GO; http://www.geneontology.org/GO.slims.shtml)
term was also determined to identify higher level annota-
tion. All GO terms were separated into the three ontologies:
biological process, cellular component, andmolecular func-
tion. Terms with low counts (<20 for biological process and
molecular function terms and<10 for the broader cellular
component terms) were excluded from this analysis, as
were taxonomic levels with low counts (<15). Full GO
terms were tested for overrepresentation among each
taxonomic level using Fisher’s exact test and adjusted for
multiple testing using the Bonferroni correction method in
R (http://www.r-project.org).
Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathways (Kanehisa andGoto 2000) were collected for each
human gene using the mappings and descriptions avail-
able (ftp://ftp.genome.jp/pub/kegg/pathway). KEGG con-
tains multiple related databases, including PATHWAY for
exploring the higher order functions of genes in terms of
the network of interactions in which they participate.KEGG
pathways are manually drawn maps that can be explored
from genes to functions or vice versa, providing an alter-
native to GO. For example, a gene could be labeled as par-
ticipating in a “chemokine signalling pathway.” Terms and
taxonomic level with low counts (<15) were excluded and
all KEGG annotations were also tested for overrepresenta-
tion among each taxonomic level as for GO terms.
Pairwise dN/dS Values
Ensembl contains pairwise dN and dS values between
pairs of genes for closely related species calculated using
codeml from the PAML package (model = 0, NSsites = 0)
(Yang 2007; Vilella et al. 2009). Saturation of the dS val-
ues may occur when the species evolutionary distance
is too large, potentially biasing the dN /dS ratio. Accord-
ingly, we limit our analysis to Chimpanzee (Pan troglodytes )
and Orangutan (Pongo pygmaeus ) in Ensembl release 56
(Flicek et al. 2009), as downloaded from the Ensembl
FTP (ftp://ftp.ensembl.org/pub). Ratios>1.5 were excluded
from our analysis. For each Chimpanzee and Orangutan
gene, and hence taxonomic level, a dN /dS ratio, mean,
standard deviation, and standard error were calculated.
Results
Dating Disease Mutations
For all human genes for which a duplicate copy (paralog)
exists, the MRD and DCA taxonomic levels (from Metazoa
to Homo sapiens , see supplementary fig. S1, Supplementary
Material online) were identified andwhether or not they are
associated with a disease gene recorded (table 1). For genes
with no identifiable duplication history, their common an-
cestor, SCA, was identified and their disease association sta-
tus recorded (table 1). Strikingly, of the 1,655 disease genes,
1,324 (80%) are associatedwith genes with a duplication his-
tory. Thus, although the majority of disease genes do have
an ancient origin (58% fromcombinedDCAandSCA) falling
in the taxonomic level Bilateria or older, understanding the
origin of disease has to consider the duplication history of
disease genes. Focusing on MRDs, we find a high number
of disease-associated genes with a duplication history at
the Chordata–Euteleostomi taxonomic level (61%; table 1).
Conversely, just 16% of disease-associated genes with a
duplication history have an MRD pre-Bilateria (table 1).
As one would expect, given the recognized importance of
whole-genome duplication events in early vertebrate evo-
lution (Blomme et al. 2006; Conrad and Antonarakis 2007;
Kasahara 2007), themajority of disease genes that have been
identified as whole-genome duplicates (860 from Makino
and McLysaght 2010) are in the Euteleostomi taxonomic
level (75%; supplementary fig. S3, Supplementary Material
online).
These results apparently suggest a bias in the origin of
disease genes. Specifically, not only do they indicate that
disease genes tend to be ancient but also that more dis-
ease genes came into existencewith the origin of vertebrates
and many of these are associated with whole-genome du-
plication. To investigate this further, we compared the dis-
tribution of SCA, DCA, and MRD across evolutionary time
to null expectations for the distribution of disease genes
by sampling from all genes 10,000 times (fig. 1A, C, and E).
Interestingly, these distributions are remarkably similar, in-
dicating that the numbers of disease genes arising in each
taxonomic level are directly correlated with the number
of genes that came into existence in that taxonomic level,
confirmed as statistically significant by regression analysis
(fig. 1B, D, and F).
To visualize the relationship between disease gene and
gene emergence, we plotted the ratio of the proportion of
disease-associated genes in each taxonomic level, relative
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Table 1. Summary of Disease-Associated, or Not, Gene Counts for Different Taxonomic Levels for MRD Nodes, DCA, and SCA.
MRD DCA SCA
Taxonomic Level Disease Nondisease Disease Nondisease Disease Nondisease
Homo sapiens 63 804 28 206 0 0
Homininae 5 233 1 81 0 29
Hominidae 10 179 4 62 0 46
Catarrhini 13 393 6 116 0 8
Primates 2 51 0 17 0 32
Eutheria 55 941 13 558 3 367
Theria 14 366 2 234 4 160
Mammalia 28 320 6 304 5 93
Amniota 17 293 17 439 9 223
Tetrapoda 31 233 17 250 3 73
Euteleostomi 806 6,141 367 3,696 51 760
Chordata 73 543 125 838 33 441
Bilateria 206 1,550 734 5,232 81 815
Fungi/Metazoa 1 8 4 22 142 1,004
Total 1,324 12,055 1,324 12,055 331 4,051
to the evolution of all genes at that taxonomic level
(fig. 1G). Comparing MRD disease-associated genes to all
MRD genes across the tree of life, the proportion of disease-
associated genes (associated with paralogs) in each time
period are relatively constant, with an average of 13% un-
til 390 Ma (fig. 1G). This indicates that the emergence of
disease-associated genes has been relatively stable in most
of evolutionary history. Since the Eutheria taxonomic level,
the proportion of disease genes drops to an average of 4%
(fig. 1G), presumably a reflection of the low numbers of
genes that have emerged since this time (7%). We also in-
vestigate the proportion of disease-associatedgenes in each
time period for singletons (SCA) and for DCA and find a
steady decline over evolutionary time (fig. 1G).
Our results, thus, demonstrate that the numbers of
disease-associated genes at the different taxonomic levels
approximately tracks the numbers of genes present at that
specific taxonomic level, up to 390 Ma (fig. 1G). After this
time, fewer novel genes came into existence either by du-
plication (21%) or de novo (6%) of which only 1.2% and
0.1% are associated with disease, respectively. The main
MRD peak approximately 500 Ma (fig. 1C) is consistent
with the documented contribution of gene duplication be-
tween the evolution of chordates and Euteleostomi and
indicates the peak of disease-associated genes is mainly a
consequence of the high levels of retained duplicates at
this time. Thus, although the majority of MRD disease-
associated genes emerged with Chordata–Euteleostomi, a
comparably high number of genes also appeared in this
period. Similarly, the additional peaks at the Catarrhini–
Hominidae taxonomic level is supported by additional gene
duplication events (Marques-Bonet et al. 2009).
Assessing Functional Relationships among Disease-
Associated Genes
Although OMIM (Hamosh et al. 2005) provides an exhaus-
tive list of disease and gene associations, it is difficult to
compare them ad hoc. Accordingly, to explore the relation-
ship between disease and each taxonomic level, we orga-
nized diseases into significantly broader and higher level
categories (see Methods), for instance, “Tay–Sachs disease”
would be classified as a “metabolic” disease. We find the
distributions of the disease categories in each taxonomic
level are broadly similar to the previous global trend (fig. 2).
In each case, we find an overrepresentation of the pre-
Metazoa and Metazoa–Bilateria taxonomic level among
orthologs (i.e., SCA and DCA) (fig. 2A) and the Chordata–
Euteleostomi taxonomic level among paralogs (i.e., MRD)
(fig. 2B) across all disease categories. Additionally, we find
no significant differences between diseases emerging at
each taxonomic level for either singletons or duplicates.
This highlights how different diseases emerge nonspecifi-
cally at each taxonomic level, in approximate proportion to
the overall emergence of genes in the different taxonomic
levels.
We also investigated the distribution of biological
functions using the GO (Harris et al. 2004) for both disease-
associated and nondisease–associated MRDs (see Meth-
ods). For each ontology, and each term, again, we find
an overrepresentation of the Chordata–Euteleostomi taxo-
nomic level. More significantly, we find very little difference
between the distribution of GO terms present in disease-
associated and nondisease–associatedMRDs. Similarly, the
distribution of terms across taxonomic level remains similar
(supplementary fig. S4, SupplementaryMaterial online).
To further explore the functional relationship within
each taxonomic level, overrepresented terms were calcu-
lated fromGO for both disease-associatedand nondisease–
associated MRDs (see Methods). We find overrepresented
biological process terms for disease-associated MRDs to be
overall higher level (hierarchically in terms of GO) for older
taxonomic levels (e.g., “transport”) than for nondisease–
associatedMRDs (supplementary tables S2 and S3, Supple-
mentary Material online). The opposite appears to be true
for younger taxonomic levels, with more low level terms
being numerous (e.g., “generation of precursor metabolites
and energy”) among disease-associatedMRDs (supplemen-
tary tables S2 and S3, SupplementaryMaterial online). This
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FIG. 1. The association of disease-associated genes with evolutionary history. Distribution of disease-associated genes for (A ) SCA, (C ) DCA, and
(E )MRDover time. The proportion of duplicates attributed towhole-genome duplication (Makino andMcLysaght 2010) are shown (hashed lines)
for Euteleostomi only, as these proportions were5% for other periods (supplementary fig. S3, Supplementary Material online). Null distribution:
random genes were selected for the distributions of MRD, DCA, and SCA genes, maintaining counts, from their respective nondisease–associated
gene lists; this was repeated 10,000 times and the upper and lower quantiles (2.5% and 97.5%, respectively) of these distributions are shown as error
bars. Taxonomic levels are indicated on the x axis of panel E and approximate evolutionary time below this. The proportions of disease-associated
genes versus nondisease–associated genes for each taxonomic level are also shown for SCA (B ), DCA (D ), and MRD (F ); polynomial regression
trend lines (degree = 2) are shown in each case: SCA: R 2 = 0.93, F statistic= 78.97, P = value 3.0× 10−7 ; DCA: R 2 = 0.98, F = 287.5, P = value
3.2 × 10−10; and MRD: R 2 = 0.99, F = 558, P = value 8.8× 10−12. (G ) Ratios of the proportions of disease-associated SCA (red), DCA (green),
and MRD (blue) among all SCA, DCA, and MRD, respectively, in each taxonomic level over approximate evolutionary time.
suggests that fundamental cellular processes evolving early
in life are more important to the cell and so less likely
be disease associated, presumably because of the proba-
ble dramatic phenotypic consequence of any disruption
(Goh et al. 2007). As expected, we find multiple overrep-
resented terms for the Chordata–Euteleostomi taxonomic
level in both disease-associated and nondisease–associated
MRDs (supplementary fig. S4 and supplementary tables S2
and S3, Supplementary Material online), although notice-
ably more in the former, again confirming high levels of du-
plication at this taxonomic level dramatically contributed
to disease emergence.
Disease-associated and nondisease–associated MRDs
share similar molecular function terms, predominantly cat-
alytic, binding, receptor, and transporter activity. Inter-
estingly, overrepresented cellular compartment terms are
sparingly distributed over time with notable omissions
from Theria to H. sapiens among disease-associated versus
nondisease–associated MRDs (supplementary fig. S4, Sup-
plementaryMaterial online).
We also investigated KEGG pathways (Kanehisa and
Goto 2000), an alternative to GO, for both disease-
associated and nondisease–associated MRDs (see Meth-
ods). Here, we are specifically interested in broad pathways
common (or not) to each taxonomic level. Similar to
the GO terms, we find comparable distributions for both
disease-associated and nondisease–associated MRDs
(supplementary fig. S5, Supplementary Material online).
Testing for overrepresentation among complete pathways
reveals the majority of KEGG terms among MRDs to be
metabolic in nature across all taxonomic level. Furthermore,
among disease-associated MRDs, signalling pathways, and
cancer terms are overrepresented in the taxonomic level
(Chordata–Tetrapoda). However, similar pathway over-
representations were observed for nondisease–associated
MRDs (supplementary fig. S5, Supplementary Material
online, green asterisks). These results corroborate our
finding that diseases emerge nonspecifically and have a
tendency to track the overall emergence of genes at each
taxonomic level.
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FIG. 2. The evolution of disease types. Disease class frequencies for disease-associated genes for (A ) orthologs and (B ) paralogs for each taxonomic
level. Disease classes correspond to high-level categories.
Positive Selection Effect
As previous studies have demonstrated, we find that
on average disease-associated genes have lower dN /dS
(nonsynonymous substitutions/synonymous substitutions)
ratio than nondisease–associated genes (Hsiao and Vitkup
2008; Cai et al. 2009). We find that this is mostly the
case across evolutionary time for orthologs (i.e., SCA
+ DCA), with a mean dN /dS of 0.73 for nondisease–
associated and 0.38 for disease-associated genes. For par-
alogs, that is, MRDs, we find a mean dN /dS of 0.46 for
nondisease–associated and 0.28 for disease-associated du-
plicates. However, in the Tetrapoda–Theria (ortholog) and
Primate (paralog) taxonomic levels, dN /dS are greater
for disease-associated genes, highlighting the value of
independently considering the many taxonomic levels,
rather, than arbitrarily condensing data into fewer uni-
form bins (Cai et al. 2009). In addition, our results indicate
that the apparent difference between “young”—defined
by Cai with respect to humans and primates onward
(Cai et al. 2009)—disease-associated and nondisease–
associated genes is based on extremely limited data
(fig. 3), 3% and 7%, respectively. As a consequence, con-
clusions drawn from such comparisons must be considered
cautiously.
Furthermore, and confirming previous work (Domazet-
Loso and Tautz 2008; Cai et al. 2009), we find an inverse re-
lationship between evolutionary rate and gene age (fig. 3);
specifically, for nondisease–associated genes, the dN /dS
ratio decreases with evolutionary time (P < 0.05 in both
cases; fig. 3). However, this is not the case for disease-
associated paralogous genes (P > 0.05; fig. 3), again, indi-
cating the importance of considering duplication history.
These observations also need to be considered cautiously
owing to limited data from Tetrapod divergence onward.
FIG. 3. Effect of positive selection on disease-associated genes. Mean dN /dS between Homo sapiens and Pan troglodytes for disease-associated
(green triangles) and nondisease–associated (blue circles) orthologs (A ) and paralogs (B ) in each taxonomic level. Category axis labels corre-
sponds to each taxonomic level. Inset bar chart displays percentage of both disease-associated and nondisease–associated genes in each taxonomic
level.
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FIG. 4. (A ) Frequencies of disease genes associated with different sizes of gene families and (B ) frequencies of unique diseases associated with the
same genes for SCA and MRD. The proportion of duplicates attributed to whole-genome duplication (Makino and McLysaght 2010) are shown
for panel A (hashed lines).
Note that we obtained similar results for the Orangutan
comparisons (P. pygmaeus ; supplementary fig. S6, Supple-
mentary Material online).
Discussion
Considering the duplication history of disease-associated
genes, we find that Mendelian diseases have a propensity
to be associated with genes that are paralogous, that is,
associated with a specific duplicated gene in the human
genome. This confirms our hypothesis on the importance
of considering both common ancestors of genes and any
duplication history when dating disease emergence. Al-
though the common ancestors of disease genes do tend
to be ancient, by mapping disease to duplication history,
we find that the majority of duplicates cluster at the di-
vergence of the bony vertebrates approximately 500–600
Ma (Chordata–Euteleostomi; fig. 1C) of whichmost of them
(80%) have been identified as being generated by whole-
genome duplication.
Interestingly, when we control for the differing gene
emergence rates throughout evolutionary time, we ob-
serve that the emergence of disease-associated genes is in
proportion to the number of nondisease-associated genes
up to approximately 390 Ma. For example, the peak at
Chordata–Euteleostomi corresponds to a substantial num-
ber of gene duplications, most of which are associated with
whole-genome duplication. Therefore, although we observe
a greater frequency of disease-associated duplicates in this
taxonomic level, we similarly observe a greater number of
duplicates. Correcting, thus, for gene emergence for the dif-
ferent taxonomic levels, we find for duplicated genes that
theproportion of disease-associatedgenes has remainedap-
proximately constant, despite the evolution (generally) of
increasing functional complexity (fig. 1).
This tendency for the emergence of disease mutations
associated with genes with a duplication history to track
the emergence of novel genes is presumably due to 1) the
hitchhiking (Smith and Haigh 1974) of disease-causing mu-
tations with beneficial mutations that have contributed to
functional evolution and/or 2) a consequence of compen-
sation by duplicate copies, permitting the accumulation
of disease-causingmutations, either because compensation
is only partial or the duplicate pairs subsequently diverge
and compensation is no longer effective (Hsiao and Vitkup
2008). If this is the case, we would predict that this will lead
to the tendency for an asymmetry in the relationship of dis-
ease genes to duplicates, that is a tendency for only one
member of a pair to have an associationwith disease. Inves-
tigating this we find that this is the case for 87% of pairs and
tobe a general rule fordifferent sizes of gene families (groups
of paralogous genes; fig. 4A ).
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Our finding that the emergence of disease-associateddu-
plicate genes has been relatively constant in evolutionary
history is, presumably, due to an upper limit of disease mu-
tations that populations can tolerate, that is, their muta-
tional load (Kimura et al. 1963; Lynch and Gabriel 1990).
Indeed, for the most part, diseases have been found to be
associated with mildly deleterious mutations that, exclud-
ing rare beneficial disease mutations (Altshuler et al. 2008),
are tolerated in the human population as they have limited
impact on reproductive success (Rice 2002; Reed and
Aquadro 2006). That there are relativelymore disease genes
associatedwith larger gene families (fig. 4A) andmore cases
of multiple diseases being associated with the same gene
for duplicates (fig. 4B) supports this “disease-tolerance”
hypothesis.
Our findings also suggest a hypothesis for the observed
relationshipbetweenhuman disease and copy number vari-
ation (Conrad and Antonarakis 2007; Zhang et al. 2009;
Cooper and Kehrer-Sawatzki 2011); that is, these types of
changes are more likely to tolerate disease mutations be-
cause they tend to be nonlethal and so can proliferate in as-
sociation with copy number variants. It is well documented
that duplication of genes leads to accelerated evolution
in one of the partners due to the relaxation of purifying
selection, which in exactly the same way will lead to the
emergence of slightly deleterious mutations, and it is these
changes that have the potential to manifest as human dis-
ease (fig. 4A). The interesting thing in terms of understand-
ing the origins of disease is how intimately linked disease is
with functional evolution. This even influences the types of
genes that proliferate in the human genome. For example,
in the case of whole-genome duplicates, these have con-
tributed significantly to evolution because dosage effects
favor their retention, resulting in a greater probability that
they will contribute to functional evolution (Hakes et al.
2007), which results in their subsequent duplication being
constrained to a relatively greater degree due to deleterious
dosage effects (Makino andMcLysaght 2010).
For genes present as singletons,we find the proportion of
disease-associated genes declines with recency, suggesting
that the mutational load tolerated by populations with re-
gard to singletonsmostly decreases with the evolution of in-
creasing functional complexity. Presumably, this is because
singletons are less likely to be associatedwith functional in-
novation so there will be limited selection pressure acting
on them, resulting in less hitchhiking of disease mutations.
In addition, unlike for paralogs, there will be no opportunity
for direct compensatory effects. A similar decreasing with
recency trend, although with a higher proportion of disease
genes, was observed for DCA (fig. 1G).
Exploring the functional relationships among taxonomic
level reveals similar patterns for the three GOs and KEGG
pathways. Disease-associated MRD tend to track in paral-
lel to MRDs in a functionally independent and nonspecific
waywith a distinct peak at bony vertebrate divergence. SCA
and DCA similarly track with an early pre-Bilateria peak
(supplementaryfigs. S4 and S5, SupplementaryMaterial on-
line). Such similarity in the functional relationshipsbetween
disease- and nondisease–associated genes has precedence,
having previously been described for GO terms (Domazet-
Loso and Tautz 2008). Additionally, we found that this
tracking is independent of the type or class of disease
(fig. 2).
Concerning the role of positive selection acting on
disease-associated genes, we propose that previously ob-
served patterns could be due to sampling effects rather
than any intrinsic properties of these genes. Previous stud-
ies have found that disease-associated genes have dN /dS
(nonsynonymous substitutions/synonymous substitutions)
ratio higher (Smith and Eyre-Walker 2003; Huang et al.
2004), lower (Hsiao and Vitkup 2008; Cai et al. 2009), or
no different to that observed for nondisease–associated
genes (Thomas and Kejariwal 2004). It is has been demon-
strated that disease-associated genes evolve at similar
rates regardless of their evolutionary age and at a slower
rate with reference to more recently evolved nondisease–
associated genes (Cai et al. 2009). We also find that
disease-associated genes tend to have lower mean non-
synonymous substitutions to synonymous substitutions ra-
tio than nondisease-associated genes. However, the lack of
data available after 390 Ma, let alone from Eutheria, pro-
hibits any particularly meaningful biological conclusions
on differences between age categories of disease genes. It is
therefore equivocal whether or not disease genes evolve at
a different rate to nondisease genes (Hsiao andVitkup 2008;
Cai et al. 2009).
In conclusion, our results demonstrate that the emer-
gence of genes associated with disease has been relatively
constant and ongoing throughout the evolution of life.
Thus, the notion of fragility in evolutionary ancient genes is a
misnomer. Rather, disease is inherent to biological systems
as they are dependent on mutation for functional innova-
tion. Interestingly, just as duplication is the key contributor
to the evolution of function,duplicated genes contribute to
more diseases than singletons and this has been relatively
stable across most of evolutionary time. A unifying explana-
tion for heritable disease, thus, is it is merely a by-product
of the evolutionary process. That is, just as mutation con-
tributes to functional innovation in concert with gene du-
plication, it will also lead to novel opportunities for new
diseases to emerge.
Supplementary Material
Supplementary tables S1–S3 and figures S1–S6 are available
atMolecular Biology and Evolution online (http://www.mbe.
oxfordjournals.org).
Acknowledgments
J.E.D. was supported by a Wellcome Trust studentship
and VIP award. Thanks to Kathryn Hentges for helpful
comments.
References
Altshuler D, Daly MJ, Lander ES. 2008. Genetic mapping in human dis-
ease. Science 322:881–888.
68
 at Periodicals D
ept on A
ugust 16, 2016
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
The Origin of Human Disease · doi:10.1093/molbev/msr111 MBE
Benton MJ, Ayala FJ. 2003. Dating the tree of life. Science 300:1698–
1700.
BentonMJ, Donoghue PCJ. 2007. Paleontological evidence to date the
tree of life.Mol Biol Evol. 24:26–53.
Blomme T, Vandepoele K, De Bodt S, Simillion C,Maere S, Van de Peer
Y. 2006. The gain and loss of genes during 600 million years of ver-
tebrate evolution. Genome Biol. 7:R43.
Cai J, Borenstein E, Chen R, Petrov D. 2009. Similarly strong purify-
ing selection acts on human disease genes of all evolutionary ages.
Genome Biol Evol. 1:131.
Conant G, Wolfe K. 2008. Turning a hobby into a job: how
duplicated genes find new functions. Nat Rev Genet. 9:938–
950.
Conrad B, Antonarakis SE. 2007. Gene duplication: a drive for pheno-
typic diversity and cause of human disease. Annu Rev Genomics
Hum Genet. 8:17–35.
Cooper D, Kehrer-Sawatzki H. 2011. Exploring the potential relevance
of human-specific genes to complex disease. Hum Genomics 5:
99–107.
Domazet-Loso T, Tautz D. 2008. An ancient evolutionary origin of
genes associated with human genetic diseases. Mol Biol Evol.
25:2699–2707.
Donoghue PCJ, Benton MJ. 2007. Rocks and clocks: calibrating the
tree of life using fossils and molecules. Trends Ecol Evol. 22:
424–431.
Edgar R. 2004. Muscle: a multiple sequence alignment method
with reduced time and space complexity. BMC Bioinformatics
5:113.
Flicek P, Aken B, Ballester B, et al. (57 co-authors). 2009. Ensembl’s 10th
year. Nucleic Acids Res 38:D557–562.
Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Baraba´si AL. 2007.
The human disease network. Proc Natl Acad Sci U S A. 104:
8685–8690.
Hakes L, Pinney J, Lovell S, Oliver S, Robertson D. 2007. All duplicates
are not equal: the difference between small-scale and genome du-
plication. Genome Biol. 8:R209.
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. 2005.
Online Mendelian Inheritance in Man (OMIM), a knowledge-
base of human genes and genetic disorders. Nucleic Acids Res. 33:
D514–D517.
Harris MA, Clark J, Ireland A, et al. (60 co-authors). 2004. The Gene
Ontology (GO) database and informatics resource. Nucleic Acids
Res. 32:D258–261.
Hedges SB, Dudley J, Kumar S. 2006. Timetree: a public knowledge-
base of divergence times among organisms. Bioinformatics 22:
2971–2972.
HsiaoT-L, VitkupD. 2008. Roleof duplicate genes in robustness against
deleterious human mutations. PLoS Genet. 4:e1000014.
Huang H,Winter EE,Wang H, et al. (12 co-authors). 2004. Evolutionary
conservation and selection of humandisease gene orthologs in the
rat and mouse genomes. Genome Biol. 5:R47.
Kanehisa M, Goto S. 2000. Kegg: Kyoto encyclopedia of genes and
genomes. Nucleic Acids Res. 28:27.
Kasahara M. 2007. The 2R hypothesis: an update. Curr Opin Immunol.
19:547–552.
KimuraM,Maruyama T, Crow J. 1963. Themutation load in small pop-
ulations. Genetics 48:1303.
Li H, Coghlan A, Ruan J, et al. (15 co-authors). 2006. Treefam: a cu-
rated database of phylogenetic trees of animal gene families. Nu-
cleic Acids Res. 34:D572–D580.
LongM, Betra´n E, ThorntonK,WangW. 2003. The origin of new genes:
glimpses from the young and old. Nat Rev Genet. 4:865–875.
Lo´pez-Bigas N, Ouzounis CA. 2004. Genome-wide identification of
genes likely to be involved in human genetic disease. Nucleic Acids
Res. 32:3108–3114.
Lynch M, Conery JS. 2000. The evolutionary fate and consequences of
duplicate genes. Science 290:1151–1155.
Lynch M, Gabriel W. 1990. Mutation load and the survival of small
populations. Evolution 44:1725–1737.
Makino T, McLysaght A. 2010. Ohnologs in the human genome are
dosage balanced and frequently associatedwith disease. Proc Natl
Acad Sci U S A. 107:9270.
Marques-Bonet T, Kidd J, Ventura M, et al. (20 co-authors). 2009. A
burst of segmental duplications in the genome of theAfrican great
ape ancestor.Nature 457:877–881.
Ohno S. 1970. Evolution by gene duplication. New York: Springer.
Reed F, Aquadro C. 2006. Mutation, selection and the future of human
evolution. Trends Genet. 22:479–484.
RiceW. 2002. Experimental tests of the adaptive significance of sexual
recombination. Nat Rev Genet. 3:241–251.
Smith J, Haigh J. 1974. The hitch-hiking effect of a favourable gene.
Genet Res. 23:23–35.
Smith NGC, Eyre-Walker A. 2003. Human disease genes: patterns and
predictions. Gene 318:169–175.
Thomas PD, Kejariwal A. 2004. Coding single-nucleotide polymor-
phisms associated with complex vs. mendelian disease: evolution-
ary evidence for differences inmolecular effects. Proc Natl Acad Sci
U S A. 101:15398–15403.
Vilella AJ, Severin J, Ureta-Vidal A, Heng L, Durbin R, Birney E.
2009. Ensemblcompara genetrees: complete, duplication-aware
phylogenetic trees in vertebrates. Genome Res . 19:327–335.
Yang Z. 2007. PAML 4: phylogenetic analysis by maximum likelihood.
Mol Biol Evol. 24:1586–1591.
Zhang F, Gu W, Hurles M, Lupski J. 2009. Copy number variation in
human health, disease, and evolution. Annu Rev Genomics Hum
Genet . 10:451–481.
69
 at Periodicals D
ept on A
ugust 16, 2016
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
